Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: gemcitabine, carboplatin
Sponsor: National University Hospital, Singapore